STAT+: Biotech mogul Arie Belldegrun extends empire with launch of $600 million credit firm https://lnkd.in/gkNTPhsJ Biotech mogul Arie Belldegrun extends his empire with the launch of a $600 million credit firm. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks #LosAngeles #OrangeCountyCA #Biotech #Lifescience #News
Los Angeles Biotech Networks’ Post
More Relevant Posts
-
SFBN Feed: BridgeBio gathers investors to launch rare disease-focused spinoff https://lnkd.in/gQEigHGr The company earlier this year spun out a cancer-focused company with $200 million. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks #BayArea #SanFrancisco #Biotech #Lifescience #News
BridgeBio gathers investors to launch rare disease-focused spinoff
https://sfbn.org
-
Life Sciences Corporate & Business Development, Strategic Planning, and Commercialization Executive
Ready. Set. Growth! Released at #BIO2024, our Biotech Benchmark Report provides new insights on the investment landscape, takes on women’s health and new policies, and answers to the biggest questions in biotech today. Download the report below! #wewillcure
Yesterday, at the Biotechnology Innovation Organization Conference, we launched our first-ever Biotech Benchmark Report 2024, where we spoke with Deerfield Management's VP of Business Development, David Greenwald, Ph.D., for the latest on real pulse of the current state of the biotech industry. Download report for more information: https://wewillcure.com/ #wewillcure #bio2024
-
Join us on June 7 for the next installment of our Startup & Accelerate webinar series. This session will focus on legal strategies and venture capital financing and market trends for biotechnology, medical device, and other life sciences emerging companies. Learn more and register: https://bit.ly/3V1GBAq #biotechnology #lifesciences
-
-
We’re preparing to relocate to a state-of-the-art facility in Q2 of 2025! This bespoke space will more than double our footprint to 25,000 square feet, fuelling our ambitious growth plans. With expanded #R&D labs and the ability to scale fermentation up to 100L, this move marks a major milestone for our team as we continue to accelerate innovation in therapeutics and sustainable biotechnology. Read the full press release here: https://ow.ly/hkaM50TXR7Y #BiotechInnovation #CRDMO #Biomanufacturing #EngineeringBiology
-
-
"Thrilled to be part of organizing the 3rd International Conference on Biotechnology! Honored to welcome esteemed doctors and scientists, pushing boundaries and shaping the future of biotech. Together, let's ignite innovation and pave the way for transformative discoveries! #BiotechConference #Innovation #ScienceLeaders"
-
-
The Synthetic Revolution You Didn’t See Coming: A Glimpse at 2024’s Most Game-Changing Biotech Inventions. #SyntheticRevolution #Biotech2024 #GameChangingInventions #BiotechInnovation Article Link: https://loom.ly/B37Blso
-
-
The Synthetic Revolution You Didn’t See Coming: A Glimpse at 2024’s Most Game-Changing Biotech Inventions. #SyntheticRevolution #Biotech2024 #GameChangingInventions #BiotechInnovation Article Link: https://loom.ly/B37Blso
-
-
Can Predictive Biotechnology Lead the Next Biotech Wave? As we almost close off 2024, it is time to take a look at the present state of predictive biotechnology, an emerging industry that has reached a critical crossroad. Article: https://qrcd.org/7WE9 By M R yuvatha, Correspondent, #siliconindia Kiran Mazumdar Shaw, Executive Chairperson and Founder - Biocon Biologics Limited Chairperson - Vision Group on Biotechnology- Government of Karnataka #Predictivebiotechnology #advancingtechnologies #transformingmarket #pharmaceuticalgiants #DepartmentofElectronics #biotechindustry #BengaluruTechSummit2024 #predictivebiotechnology #AIdrivensolutions #transformationalsolutions
Can Predictive Biotechnology Lead the Next Biotech Wave?
news.siliconindia.com
-
Exciting times in biotech! The first half of 2024 has seen near-record investment levels. Check out the EY German Biotechnology Report 2024 to see how we're part of this thriving sector.
German Biotechnology Report 2024
ey.smh.re
-
Exciting times in biotech! The first half of 2024 has seen near-record investment levels. Check out the EY German Biotechnology Report 2024 to see how we're part of this thriving sector.
German Biotechnology Report 2024
ey.smh.re
